Beclin 1 acetylation impairs the anticancer effect of aspirin in colorectal cancer cells

Oncotarget. 2017 Aug 19;8(43):74781-74790. doi: 10.18632/oncotarget.20367. eCollection 2017 Sep 26.

Abstract

Regular use of aspirin can reduce cancer incidence, recurrence, metastasis and cancer-related mortality. Aspirin suppresses proliferation and induces apoptosis and autophagy in colorectal cancer cells, but the precise mechanism is not clear. In this study, we demonstrated that aspirin induced autophagosome formation in colorectal cancer cells, but autophagic degradation was blocked through aspirin-mediated Beclin 1 acetylation. Blocked autophagic degradation weakened aspirin-induced cell death. Collectively, our findings indicate the dual roles of aspirin on autophagy, and demonstrate a new mechanism by which Beclin 1 acetylation impairs the anticancer effect of aspirin in colorectal cancer cells.

Keywords: Beclin 1; acetylation; aspirin; autophagy; colorectal cancer.